SS
AZN icon

SBI Securities’s AstraZeneca AZN Stock Holding History

SBI Securities’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$617K Buy
3,256
+93
+3% +$17.5K 0.01% 373
2026
Q1 		$624K Buy
3,163
+157
+5% +$30.3K 0.02% 354
2025
Q4 		$553K Sell
3,006
-192
-6% -$33.7K 0.01% 380
2025
Q3 		$491K Sell
3,198
-84
-3% -$12.7K 0.01% 392
2025
Q2 		$459K Sell
3,282
-134
-4% -$18.8K 0.01% 389
2025
Q1 		$502K Buy
3,416
+376
+12% +$54.4K 0.02% 339
2024
Q4 		$398K Buy
+3,040
New +$426K 0.01% 389

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SBI Securities's AZN Position: Q2 2026 in Review

SBI Securities increased its AstraZeneca (AZN) stake by 2.9% in Q2 2026, buying an estimated $17.5K and bringing the position to 3,256 shares worth $617K. The position accounts for 0.01% of the portfolio, ranked #373.

SBI Securities first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. The position peaked at $624K in Q1 2026. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • SBI Securities held 3,256 shares of AstraZeneca worth $617K as of Q2 2026.
  • SBI Securities bought 93 AstraZeneca shares in Q2 2026, an estimated $17.5K.
  • AstraZeneca made up 0.01% of SBI Securities's portfolio in Q2 2026, its #373 holding.
  • SBI Securities first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's AstraZeneca position peaked at $624K in Q1 2026.
  • 1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.